ORCID as entered in ROS
https://orcid.org/0000-0002-4560-0259
Select Publications
Conference Papers
, 2005, 'Altered ErbB3 receptor mRNA in the dorsolateral prefrontal cortex in schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, GA, Atlanta, pp. 25S - 25S, presented at
, 2005, 'Expression of ErbB 2, 3 and 4 protein in the frontal cortex rhesus macaque monkey', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, GA, Atlanta, pp. 182S - 183S, presented at
, 2005, 'Expression of estrogen receptor alpha exon-deleted mRNA variants in the frontal cortex of patients with major mental illness', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, GA, Atlanta, pp. 54S - 55S, presented at
, 2005, 'Widespread expression of ErbB2, 3 and 4 mRNA in the juvenile and adult monkey brain', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, GA, Atlanta, pp. 55S - 55S, presented at
, 2005, 'Decrease in BDNF and TRKB mrna levels across multiple cortical areas in schizophrenia, bipolar disorder and depression', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, GA, Savannah, pp. 273 - 273, presented at
, 2005, 'The NRG1/ErbB4 signaling pathway in schizophrenia. From upstream effectors to downstream intracellular signaling networks', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, GA, Savannah, pp. 284 - 285, presented at
, 2005, 'Alterations of neuregulin1 and ErbB4 expression in the cerebellum in schizophrenia', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, GA, Savannah, pp. 260 - 260, presented at
, 2004, 'Reduction in estrogen receptor alpha rnRNA levels in the anterior hippocampus of patients with schizophrenia', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, PR, San Juan, pp. S220 - S221, presented at
, 2004, 'Small myelin-associaed glycoprotein (S-Mag) gene expression during normal human development and in elderly schizophrenics', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, PR, San Juan, pp. S112 - S112, presented at
, 2004, 'Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, PR, San Juan, pp. S56 - S56, presented at
, 2004, 'Levels of dysbindin, a schizophrenia susceptibility gene, are reduced in the frontal cortex of patients with schizophrenia.', in JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, AMER ASSN NEUROPATHOLOGISTS INC, OH, Cleveland, pp. 521 - 521, presented at
, 2004, 'Age-related regional expression patterns of estrogen receptor alpha and glucocorticoid receptor mRNA in the human hippocampus', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, NEW YORK, pp. 117S - 118S, presented at
, 2004, 'Dysbindin protein is decreased in the dorsolateral prefrontal cortex of schizophrenia patients', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, NEW YORK, pp. 116S - 116S, presented at
, 2004, 'Expression of Neuregulin-1, a schizophrenia susceptibility gene, in the normal human brain and in schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, NEW YORK, pp. 198S - 199S, presented at
, 2004, 'Selection criteria for establishing a brain collection to study gene expression in schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, NEW YORK, pp. 79S - 79S, presented at
, 2003, 'Antipsychotic drugs and BrdU incorporation in the adult rat hippocampus', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CALIFORNIA, SAN FRANCISCO, pp. 140S - 140S, presented at
, 2003, 'The schizophrenia susceptibility gene dysbindin (dtnbp1, 6p22.3): Analysis of haplotypes, intermediate phenotypes and alternative transcripts', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CALIFORNIA, SAN FRANCISCO, pp. 167S - 168S, presented at
, 2003, 'Does synaptic pathology in schizophrenia involve a selective dendritic spine deficit? A study of spinophilin and MAP2 gene expression in the hippocampus', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, COLORADO, COLORADO SPINGS, pp. 72 - 73, presented at
, 2003, 'Low glycogen synthase kinase-3 beta in schizophrenia - Genetic marker or consequence of neurodevelopmental insult', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, COLORADO, COLORADO SPINGS, pp. 64 - 64, presented at
, 2003, 'Neuronal gene expression is decreased in prefrontal cortex in schizophrenia', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, COLORADO, COLORADO SPINGS, pp. 67 - 67, presented at
, 2003, 'Reduction of GAD-67 MRNA in the striatum of patients with schizophrenia and bipolar disorder', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, COLORADO, COLORADO SPINGS, pp. 66 - 66, presented at
, 2002, 'Expression analysis of the 6p22.3 gene dysbindin (DTNBP1), a positional candidate susceptibility gene for schizophrenia.', in AMERICAN JOURNAL OF MEDICAL GENETICS, WILEY-LISS, BELGIUM, BRUSSELS, pp. 741 - 741, presented at
, 2002, 'Estrogen receptor in schizophrenia: In the wrong place at the right time', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, pp. 100S - 100S, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000174980400281&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2001, 'Decreased gene expression of muscarinic M1 and M4 receptors in prefrontal cortex of patients with schizophrenia', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, pp. 51 - 51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168411700166&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2001, 'Expression of full-length trkB mRNA in hippocampus of patients with schizophrenia', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168411700188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2000, 'Extraction of total RNA in human brain post-mortem tissue: Effect of diagnosis on RNA yield', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, pp. 41S - 41S, http://dx.doi.org/10.1016/S0006-3223(00)00399-1
, 2000, 'Muscarinic receptor protein and mRNA in DLPFC of schizophrenia and affective disorder', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, pp. 41S - 41S, http://dx.doi.org/10.1016/S0006-3223(00)00398-X
, 2000, 'Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, pp. 111 - 112, http://dx.doi.org/10.1016/S0920-9964(00)90567-X
, 1999, 'Evidence of neurogenesis in the subependymal zone of postnatal human brain', in JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, AMER ASSN NEUROPATHOLOGISTS INC, pp. 519 - 519, http://dx.doi.org/10.1097/00005072-199905000-00050
, 1999, 'TrkB receptor expression in prefrontal cortex of schizophrenic and control subjects', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, pp. 41S - 42S, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079911600134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1999, 'Effects of postnatal development on gene expression of dopamine receptors in the human prefrontal cortex', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079061400218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Posters
, 2011, 'Altered expression of apoptosis-associated messenger RNAs in prefrontal cortex from patients with schizophrenia', online, pp. 118 - 118, presented at Australian Neuroscience Society 31st Annual Meeting, Auckland, 31 January 2011 - 03 February 2011
Conference Presentations
, 2006, 'Reduced dysbindin (DTNBP1) mRNA in hippocampus of patients with schizophrenia.', England, http://dx.doi.org/10.1017/S0924270800031719
Conference Abstracts
, 2022, 'THE ROLE OF THE MICROBIOME AND METABOLIC SYNDROME IN SCHIZOPHRENIA AND EARLY PSYCHOSIS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 189 - 189, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000792769900448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'P525. Cell Type-Specific Manifestations of Cortical Thickness Heterogeneity in Schizophrenia', in Biological Psychiatry, Elsevier BV, Vol. 91, pp. S301 - S301, http://dx.doi.org/10.1016/j.biopsych.2022.02.762
, 2020, 'REDUCED CHEMOKINE SIGNALLING CAPACITY IS ASSOCIATED WITH INHIBITORY INTERNEURON DYSFUNCTION IN SUBCORTICAL BRAIN REGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, Vol. 46, pp. S202 - S203, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), ITALY, Florence, 04 April 2020 - 08 April 2020
, 2019, 'Brain-Periphery Inflammatory Markers in Individuals at Clinical High Risk for Psychosis', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, FL, Orlando, Vol. 44, pp. 248 - 248, presented at 58th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), FL, Orlando, 08 December 2019 - 11 December 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509665600466&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'In Vivo Imaging of Translocator Protein in Chronic Cannabis Users', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, FL, Orlando, Vol. 44, pp. 355 - 356, presented at 58th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), FL, Orlando, 08 December 2019 - 11 December 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509665600648&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Mapping Changes in Expression of Neuroinflammatory Genes HIVEP2 and SERPINA3 in High Inflammation Biotype Schizophrenia: Regional and Cellular Divergence Within the Dorsolateral Prefrontal Cortex', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, FL, Orlando, Vol. 44, pp. 337 - 337, presented at 58th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), FL, Orlando, 08 December 2019 - 11 December 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509665600617&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Neuroinflammation Biotypes in Schizophrenia: Toward Mechanistic Validation of Shn2 Ko Mice as an Experimental System', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, FL, Orlando, Vol. 44, pp. 340 - 341, presented at 58th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), FL, Orlando, 08 December 2019 - 11 December 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509665600622&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Decreased cortical human immunodeficiency virus type i enhancer binding protein 2 in schizophrenia is driven by patients with high inflammation', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER, DENMARK, Copenhagen, Vol. 29, pp. S155 - S156, presented at 32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP), DENMARK, Copenhagen, 07 September 2019 - 10 September 2019, http://dx.doi.org/10.1016/j.euroneuro.2019.09.245
, 2019, 'Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER, DENMARK, Copenhagen, Vol. 29, pp. S82 - S82, presented at 32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP), DENMARK, Copenhagen, 07 September 2019 - 10 September 2019, http://dx.doi.org/10.1016/j.euroneuro.2019.09.149
, 2019, 'Dysregulation of Brain-Derived Neurotrophic Factor (BDNF) and Stress-Related mRNA Expression in the Midbrain of Maternally Separated Rodents', in EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, TAYLOR & FRANCIS LTD, Vol. 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000473714500312&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S44 - S45, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.121
, 2019, 'Testosterone Modulation of Sex Steroid and Dopamine-Related mRNAs During Adolescence in the Mesolimbic Pathway', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S280 - S281, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.711
, 2019, 'Transcriptional Changes in the Stress Pathway are Related to Symptoms in Schizophrenia and to Mood in Schizoaffective Disorder', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S273 - S274, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.694
, 2019, 'COGNITIVE RESERVE ATTENUATES AGE-RELATED COGNITIVE DECLINE IN THE CONTEXT OF ACCELERATED BRAIN AGEING IN SCHIZOPHRENIA-SPECTRUM DISORDERS: EVIDENCE FOR ACTIVE COMPENSATION', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, FL, Orlando, Vol. 45, pp. S91 - S92, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), FL, Orlando, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000466725400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, FL, Orlando, Vol. 45, pp. S318 - S318, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), FL, Orlando, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1093/schbul/sbz020.578
, 2018, 'THE ROLE OF LONG INTERSPERSED ELEMENT-1 RETROTRANSPOSONS IN SCHIZOPHRENIA', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER, SCOTLAND, Glasgow, Vol. 29, pp. 1259 - 1260, presented at 26th World Congress of Psychiatric Genetics (WCPG), SCOTLAND, Glasgow, 11 October 2018 - 15 October 2018, http://dx.doi.org/10.1016/j.euroneuro.2018.08.351
, 2018, 'Differential expression of synaptic and interneuron genes in the aging human prefrontal cortex [Abstract O5-04-06]', in Alzheimer's & Dementia, Elsevier BV, Chicago, USA, Vol. 14, pp. P1654 - P1655, presented at Alzheimer’s Association International Conference (AAIC) 2018, Chicago, USA, 22 July 2018 - 26 July 2018, http://dx.doi.org/10.1016/j.jalz.2018.06.3018
Filter by type
https://orcid.org/0000-0002-4560-0259